Persistence and Compliance with Cardiovascular Drug Therapy Among Seniors

Promoting compliance with tuberculosis drug therapy.

The recent increase in the notifications of tuberculosis infections has focused the attention of healthcare professionals on reasons for the disease's resurgence. This article describes how directly observed therapy and an enlightened approach to health promotion for groups of people perceived as being at risk, could prevent further increases in incidence.

Persistence and compliance with newly initiated antihypertensive drug treatment in patients with chronic kidney disease

BACKGROUND Patients with chronic kidney disease initiating an antihypertensive drug (AH) treatment must persist and comply with it to slow disease progression and benefit from the reduction of cardiovascular morbidity and mortality. OBJECTIVES This study evaluates the persistence and compliance with AH treatment and identifies the associated factors among chronic kidney disease patients who i...

RAMADAN AND CARDIOVASCULAR DRUG USE

The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review

BACKGROUND Sub optimal levels of compliance and persistence with bisphosphonates are potentially compromising the reduction of post menopausal osteoporotic (PMO) fracture risk. METHODS A structured literature search (1990-2006) was performed to identify primary research studies evaluating the relationship between compliance and persistence with bisphosphonates and post menopausal osteoporotic...

Herbal drug leaflets: are they in compliance with standards?

Leaflets inside pharmaceutical packages should include focal points about medicines being used by patients. The current study was designed to assess the compliance of information cited in herbal medicine leaflets with the standards released by the Ministry of Health and Medical Education of Iran (MHMEI). Leaflets of commonly used herbal pharmaceutical products sold in pharmacies of Iran were co...